CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
Dexamethasone iv injection +2 moredrug
Likely dose
Dexamethasone iv injection 5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01639599
NCT01639599N/ACompleted
CompareCT.gov

Phase 4 Study of Optimal Dose of Haloperidol

The Catholic University of Korea·interventional·Posted Jul 12, 2012·Updated Sep 9, 2020

In Brief

A clinical study evaluating Dexamethasone iv injection and Dexamethasone, haloperidol for Gynecological Disease. Completed, enrolled 150 participants.

Detailed Summary

Low-dose haloperidol is known to be effective for the treatment of postoperative nausea and vomiting (PONV). However, precise dose-response studies have not been completed, especially in patients at high risk for PONV who require combination therapy. This study sought to identify the optimal dose of haloperidol that could be combined with dexamethasone without adverse effects in high-risk PONV patients receiving intravenous patient-controlled anesthesia (IV PCA) after gynecological laparoscopic surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGynecological Disease
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 12, 2012
Enrollment StartMar 1, 2012
Primary CompletionDec 1, 2012
Study CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 14.0 years ago

Interventions

Dexamethasone iv injectiondrug

Dexamethasone 5mg iv during anesthesia induction

Dexamethasone, haloperidoldrug

dexamethasone + haloperidol 1mg

Dexamethasone, haloperidoldrug

Active Comparator: dexamethasone + haloperidol 2mg